Proud to present the progress of ECMM Candida IV study at #ISHAM2025

Still open for participation!

@martinhoenigl.bsky.social

23.05.2025 08:25 — 👍 4    🔁 2    💬 0    📌 0

Antifungal tolerance, resistance and clinical outcomes on candidemia caused by non-albicans Candida  - ECMM ECMM Candida IV Antifungal tolerance, resistance and clinical outcomes on candidemia caused by non-albicans Candida  Observation periods/Timeline Observation period: April 1st, 2024 – September 30th, ...

Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: www.ecmm.info/working-grou...

@martinhoenigl.bsky.social

24.04.2025 16:34 — 👍 5    🔁 3    💬 0    📌 0

ECMM Candida IV Study is still open for participation

Global study on non-albicans candidemia

Requirements:

🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available

@martinhoenigl.bsky.social

08.04.2025 06:59 — 👍 7    🔁 6    💬 0    📌 0